Pioglitazone Lowers Risk Of Heart Attack, Stroke And Death But Raises Heart Failure Risk Among Diabetes Type 2 Patients

September 11th, 2007 | Category: Diabetes

Pioglitazone, a glycemic control drug for humans with Type 2 Diabetes, appreciably lowers the risk of stroke, heart attack and death, but raises serious heart failure risk, says a report in the Journal

of the American Medical organization (JAMA), September 12 issue. A. Michael Lincoff, M.D. [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Diabetics Have Same Risk For Heart Attack, Stroke Or Death From Cardiovascular Diseases As folks Who’ve Already Had A Heart Attack
  • Type 2 Diabetes Patients More Likely To Develop Congestive Heart Failure When Given Rosiglitazone Or Pioglitazone
  • Long-term Rosiglitazone Use Linked To Raised Heart Attack And Heart Failure Risk
  • ACTOS Not Associated With Increased Risk Of Heart Attack, Stroke, Or Death: Takeda Statement Published In JAMA
  • Risk Of Death For Heart Attack Patients Raised By Clinical Depression Even Years Later

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.